Ajooni Biotech Limited (NSE:AJOONI)
India · Delayed Price · Currency is INR 3.720
-0.030 (-0.80%)
Aug 21, 2026, 3:29 PM IST
Ajooni Biotech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 641 | 661 | 965 | 517 | 346 | 673 | |
Market Cap Growth | -29.94% | -31.43% | 86.60% | 49.37% | -48.61% | 121.38% |
Enterprise Value | 906 | 763 | 809 | 534 | 194 | 747 |
Last Close Price | 3.72 | 3.84 | 5.60 | 5.20 | 3.48 | 10.46 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 17.15 | 15.30 | 28.61 | 23.92 | 30.77 | 64.20 |
PS Ratio | 0.30 | 0.36 | 0.83 | 0.64 | 0.47 | 0.91 |
PB Ratio | 0.70 | 0.73 | 1.10 | 1.21 | 0.83 | 4.11 |
P/TBV Ratio | 0.70 | 0.73 | 1.10 | 1.21 | 0.83 | 4.11 |
P/FCF Ratio | - | - | - | 2.99 | - | 43.17 |
P/OCF Ratio | - | - | - | 2.26 | - | 18.28 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.42 | 0.41 | 0.70 | 0.67 | 0.26 | 1.01 |
EV/EBITDA Ratio | 10.09 | 8.79 | 16.04 | 19.30 | 6.51 | 23.91 |
EV/EBIT Ratio | 13.96 | 11.79 | 20.48 | 28.21 | 9.82 | 34.68 |
EV/FCF Ratio | - | - | - | 3.09 | - | 47.89 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.29 | 0.20 | 0.02 | 0.05 | 0.12 | 0.33 |
Debt / EBITDA Ratio | 3.00 | 2.05 | 0.38 | 0.78 | 1.74 | 1.71 |
Debt / FCF Ratio | - | - | - | 0.13 | - | 3.43 |
Net Debt / Equity Ratio | 0.29 | 0.19 | -0.06 | 0.04 | 0.11 | 0.32 |
Net Debt / EBITDA Ratio | 2.96 | 2.00 | -1.06 | 0.63 | 1.53 | 1.66 |
Net Debt / FCF Ratio | - | -0.73 | 0.27 | 0.10 | -0.65 | 3.32 |
Asset Turnover | 1.93 | 1.72 | 1.63 | 1.51 | 1.70 | 2.60 |
Inventory Turnover | 5.20 | 4.66 | 4.93 | 6.29 | 10.21 | 11.37 |
Quick Ratio | 0.54 | 0.69 | 4.99 | 4.47 | 1.41 | 1.40 |
Current Ratio | 2.36 | 2.72 | 12.86 | 10.74 | 2.28 | 2.18 |
Return on Equity (ROE) | 4.40% | 4.82% | 5.16% | 5.12% | 3.88% | 6.55% |
Return on Assets (ROA) | 3.61% | 3.75% | 3.46% | 2.23% | 2.81% | 4.72% |
Return on Invested Capital (ROIC) | 4.24% | 5.09% | 4.84% | 3.01% | 4.15% | 7.09% |
Return on Capital Employed (ROCE) | 7.00% | 7.00% | 4.40% | 4.30% | 4.50% | 11.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 6.20% | 6.53% | 3.50% | 4.18% | 3.25% | 1.56% |
FCF Yield | -37.09% | -35.93% | -20.50% | 33.48% | -20.05% | 2.32% |
Buyback Yield / Dilution | - | -0.37% | -96.59% | -46.51% | -18.35% | -1.00% |